Diagnostic Approach to Acquired TTP | AJMC

Congenital TTP: Disease Overview, Diagnosis & Treatment Strategies

Video: Thrombotic thrombocytopenic purpura - Video Explanation! | Osmosis | Osmosis

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura In acquired thrombotic thrombocytopenic purpura (TTP), an immune-mediated deficiency of the von Willebrand factor–cleaving protease ADAMTS13 allows unrestrained adhesion of von Willebrand factor multimers to platelets and microthrombosis, which result in thrombocytopenia, hemolytic anemia, and tissue ischemia. Caplacizumab, an anti–von Willebrand factor humanized, bivalent variable-domain-only immunoglobulin fragment, inhibi

Update on Immune-TTP Treatment Including PLEX, Rituximab, and Caplacizumab

2021 Update on ITP and TTP: Guideline Takeaways for 1st and 2nd Line Therapies